Eli Lilly and Company (SWX:LLY)
570.00
0.00 (0.00%)
At close: May 14, 2025
Eli Lilly and Company Revenue
Eli Lilly and Company had revenue of $12.73B USD in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly and Company had annual revenue of $45.04B with 32.00% growth.
Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
12.45
Revenue / Employee
$1.04M
Employees
47,000
Market Cap
539.37B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.04B | 10.92B | 32.00% |
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 62.40B |
Novartis AG | 47.05B |
Lonza Group AG | 6.57B |
Alcon | 8.98B |
Galderma Group AG | 4.02B |
Straumann Holding AG | 2.50B |
Sandoz Group AG | 9.41B |
Sonova Holding AG | 3.87B |
Eli Lilly and Company News
- 20 hours ago - Unpacking the Latest Options Trading Trends in Eli Lilly - Benzinga
- 1 day ago - Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. - Barrons
- 1 day ago - Tech sector leads: Nvidia and Amazon surge amidst healthcare tumble - Forexlive
- 2 days ago - NVO, PFE and LLY Forecast – Pharma Stocks React to Drug Order Trump Signs - FX Empire
- 2 days ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - Benzinga
- 2 days ago - 50 Fortune World's Most Admired Companies (FWMAC): 24 "Safer", 1 Ideal Buy - Seeking Alpha
- 2 days ago - Trump calls out weight-loss drugs as target of price-cut push - Reuters
- 2 days ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC